The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
about
Prostate mechanical imaging: a new method for prostate assessmentJoint effects between five identified risk variants, allergy, and autoimmune conditions on glioma riskScreening for prostate cancerScreening for prostate cancerMortality results from a randomized prostate-cancer screening trialCumulative incidence of false-positive results in repeated, multimodal cancer screeningAllellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.Management of relapsed ovarian cancer: a reviewSerum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trialMultiple loci identified in a genome-wide association study of prostate cancerAlcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers.Quantification of length-bias in screening trials with covariate-dependent test sensitivity.A Note on Penalized Regression Spline Estimation in the Secondary Analysis of Case-Control Data.Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient.A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Creation of a CT Image Library for the Lung Screening Study of the National Lung Screening Trial.High spectral and spatial resolution MRI of age-related changes in murine prostate.Collecting 48,000 CT exams for the lung screening study of the National Lung Screening Trial.Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CohortColorectal cancer: screening.Factors related to use of prostate cancer screening: the Alberta Tomorrow ProjectSerum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.Dietary iron, iron homeostatic gene polymorphisms and the risk of advanced colorectal adenoma and cancer.The National Lung Screening Trial: overview and study design.LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participantsFinasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilitiesMetabolites of tobacco smoking and colorectal cancer riskEvaluation of polygenic risk scores for predicting breast and prostate cancer risk.Genome-wide association study of relative telomere length.Effects of electron-beam irradiation on buccal-cell DNA.Characterizing genetic risk at known prostate cancer susceptibility loci in African AmericansAnthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).Cancer screening trials: nuts and bolts.Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma riskCross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortiaThe association of telomere length and genetic variation in telomere biology genes.Biospecimens, biobanking and global cancer research collaborationsRisk of perforation after colonoscopy and sigmoidoscopy: a population-based study.Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.
P2860
Q22162491-3633540F-EE84-46A3-A9B7-B1CFDE12D1A1Q23917504-21685F58-EDED-4439-A7C6-99E557D668FAQ24201690-F9F9F1DC-5495-49A3-B85D-48808207266EQ24245476-3802CD63-012A-41A8-A5F3-560D0CA76CC5Q24601536-2EE867D7-7C7A-4DA9-BEF8-0A2170D304E1Q24642313-888B53A9-29F0-44AD-BD4F-056BEC8E930CQ25255846-1C1FD9A4-7BAB-4A56-A502-C51FFC80E986Q26741755-5CCA1A10-A404-418B-8F13-69FCB8AB28D3Q28820954-B53E90DA-052D-4B74-AA1D-BDC962681DF8Q28943507-40166331-A39A-4A4F-B79A-3B830BB6977AQ30277165-7DECDE68-E83A-47AE-9AEF-9D6144EE70EEQ30299933-3BC2482A-C9D2-4819-9694-C55680918BCDQ30795103-0449F9DA-EBA5-414A-8C36-289793EFD42BQ30994622-3337D434-55F5-47D8-AEDC-7E97E510DE3EQ33226895-D48ED2D0-CFF4-4C1B-B5BF-82F73C5ECEC3Q33247188-7DBC42D7-705D-4926-99B8-3007B1F25F34Q33363375-96A18EAE-CC27-4DCE-9E4A-5D3C45145E99Q33367598-9E4C9E3C-0912-487F-9A9C-5BED7B2A99A0Q33418922-7663EB22-E5AB-4F9A-B305-0EF6AB336D46Q33448195-B1380D16-6EC4-447C-947E-3808FCD8E84CQ33572535-EACBC3F5-C5CA-4FAB-BEEB-064C459A3BA0Q33688029-37E64CCF-648E-479A-A22C-2992AE16C51BQ33705220-3F88E53B-08B4-45F4-AC57-6E6056B9C351Q33736528-5CE09B13-8AB0-475B-B452-B3D697E8E281Q33740684-DC72C2CB-E588-4348-963D-8592EC96A8DCQ33750580-B292CE20-55DA-4DFE-A011-D1A83C9CD38AQ33803097-BF6AB83C-D624-467B-9BDF-EB91D9D9341FQ33827689-69622406-66D0-415B-8AB1-7E29009245E9Q33873837-1481D08B-5609-4510-B28D-B1F8455C3564Q33900326-F72A37B4-A3B6-4BD9-905C-7CC4ACADA6D3Q33906376-D066A0E5-A752-43A2-A691-B3A6C1D1C287Q33921139-841345A0-A813-4B2E-BEAA-8765E7021642Q34059780-602F6ABA-600F-4164-B1D9-AA69F4D3F6B3Q34073143-EBD67DEB-9857-46DD-A418-B5FE0AB210BCQ34076979-D5E929DE-073A-4AAB-AC2B-2E0ED287AF4CQ34096825-0FF8502B-FE2A-41D9-A9A6-ED79251DD223Q34101736-5E9CC673-413A-4126-A3A8-ACEDDEE10470Q34135170-2B353D14-17D7-4E17-BB2A-0FF866D940C8Q34175299-7B1B0CC5-E496-4AF4-9869-465852654473Q34252079-C082D79A-A2B6-460F-B6C0-5EB7FA793B0F
P2860
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The Prostate, Lung, Colorectal ...... ory, organization, and status.
@en
type
label
The Prostate, Lung, Colorectal ...... ory, organization, and status.
@en
prefLabel
The Prostate, Lung, Colorectal ...... ory, organization, and status.
@en
P2093
P1476
The Prostate, Lung, Colorectal ...... ory, organization, and status.
@en
P2093
B S Kramer
J K Gohagan
P C Prorok
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
P304
P356
10.1016/S0197-2456(00)00097-0
P407
P433
P577
2000-12-01T00:00:00Z